In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity

CONTEXT: Shengmai injection (SMI) has been used to treat heart failure. OBJECTIVE: This study determines the molecular mechanisms of SMI against cardiotoxicity caused by doxorubicin (DOX). MATERIALS AND METHODS: In vivo, DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Peng, Gao, Ge, Zhao, Chun-chun, Li, Jing-ya, Peng, Jian-fei, Wang, Shu-shu, Song, Rui, Shi, Hui, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933025/
https://www.ncbi.nlm.nih.gov/pubmed/35298357
http://dx.doi.org/10.1080/13880209.2022.2046801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933025/
https://www.ncbi.nlm.nih.gov/pubmed/35298357
http://dx.doi.org/10.1080/13880209.2022.2046801

Ejemplares similares